Dimension Therapeutics, Inc. Operating Expenses
Dimension Therapeutics, Inc. reported Operating Expenses of $21.45 million for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2017-11-06
- Dimension Therapeutics, Inc. operating expenses for the quarter ending 2017-09-30 was $21.45M, a 25.45% increase year-over-year.
- Dimension Therapeutics, Inc. operating expenses for the quarter ending 2017-06-30 was $16.70M, a 15.36% increase year-over-year.
- Dimension Therapeutics, Inc. operating expenses for the quarter ending 2017-03-31 was $17.15M, a 45.97% increase year-over-year.
- Dimension Therapeutics, Inc. operating expenses for the quarter ending 2016-12-31 was $17.20M, a 51.38% increase year-over-year.
- Dimension Therapeutics, Inc. operating expenses for fiscal 2016 was $60.52M, a 41.69% increase from fiscal 2015.
- Dimension Therapeutics, Inc. operating expenses for fiscal 2015 was $42.72M, a 172.05% increase from fiscal 2014.
- Dimension Therapeutics, Inc. operating expenses for fiscal 2014 was $15.70M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2017-09-30 | $21.45M 10-Q · filed 2017-11-06 | $38.15M derived: sum of 2 quarters · filed 2017-11-06 | $55.30M 10-Q · filed 2017-11-06 | $72.50M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-06-30 | $16.70M 10-Q · filed 2017-08-08 | $33.84M 10-Q · filed 2017-08-08 | $51.04M derived: sum of 3 quarters · filed 2017-08-08 | $68.14M derived: sum of 4 quarters · filed 2017-11-06 |
| 2017-03-31 | $17.15M 10-Q · filed 2017-05-10 | $34.34M derived: sum of 2 quarters · filed 2017-05-10 | $51.45M derived: sum of 3 quarters · filed 2017-11-06 | $65.92M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-12-31 | $17.20M 10-K · filed 2017-03-09 | $34.30M derived: sum of 2 quarters · filed 2017-11-06 | $48.77M derived: sum of 3 quarters · filed 2017-11-06 | $60.52M 10-K · filed 2017-03-09 |
| 2016-09-30 | $17.10M 10-Q · filed 2017-11-06 | $31.58M derived: sum of 2 quarters · filed 2017-11-06 | $43.32M 10-Q · filed 2017-11-06 | $54.68M derived: sum of 4 quarters · filed 2017-11-06 |
| 2016-06-30 | $14.48M 10-Q · filed 2017-08-08 | $26.22M 10-Q · filed 2017-08-08 | $37.58M derived: sum of 3 quarters · filed 2017-08-08 | $50.29M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $11.75M 10-Q · filed 2017-05-10 | $23.11M derived: sum of 2 quarters · filed 2017-05-10 | $35.81M derived: sum of 3 quarters · filed 2017-05-10 | $47.50M derived: sum of 4 quarters · filed 2017-05-10 |
| 2015-12-31 | $11.36M 10-K · filed 2017-03-09 | $24.07M derived: sum of 2 quarters · filed 2017-03-09 | $35.76M derived: sum of 3 quarters · filed 2017-03-09 | $42.72M 10-K · filed 2017-03-09 |
| 2015-09-30 | $12.71M 10-K · filed 2017-03-09 | $24.39M derived: sum of 2 quarters · filed 2017-03-09 | $31.35M 10-Q · filed 2016-11-10 | $37.36M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-06-30 | $11.69M 10-K · filed 2017-03-09 | $18.65M 10-Q · filed 2016-08-11 | $24.66M derived: sum of 3 quarters · filed 2017-03-09 | $28.32M derived: sum of 4 quarters · filed 2017-03-09 |
| 2015-03-31 | $6.96M 10-K · filed 2017-03-09 | $12.97M derived: sum of 2 quarters · filed 2017-03-09 | $16.64M derived: sum of 3 quarters · filed 2017-03-09 | $20.70M derived: sum of 4 quarters · filed 2017-03-09 |
| 2014-12-31 | $6.01M 10-K · filed 2016-03-24 | $9.68M derived: sum of 2 quarters · filed 2016-03-24 | $13.75M derived: sum of 3 quarters · filed 2016-03-24 | $15.70M 10-K · filed 2017-03-09 |
| 2014-09-30 | $3.67M 10-K · filed 2016-03-24 | $7.74M derived: sum of 2 quarters · filed 2016-03-24 | $9.69M 10-Q · filed 2015-12-04 | |
| 2014-06-30 | $4.07M 10-K · filed 2016-03-24 | $6.03M derived: sum of 2 quarters · filed 2016-03-24 | ||
| 2014-03-31 | $1.96M 10-K · filed 2016-03-24 | |||
| 2013-12-31 | $3.17M 10-K · filed 2016-03-24 |